BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

756 related articles for article (PubMed ID: 12560938)

  • 1. Granulocyte transfusions from G-CSF-stimulated donors for the treatment of severe infections in neutropenic pediatric patients with onco-hematological diseases.
    Cesaro S; Chinello P; De Silvestro G; Marson P; Picco G; Varotto S; Pittalis S; Zanesco L
    Support Care Cancer; 2003 Feb; 11(2):101-6. PubMed ID: 12560938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of granulocyte transfusions for neutropenia-related infections: retrospective analysis of predictive factors.
    Rutella S; Pierelli L; Sica S; Serafini R; Chiusolo P; Paladini U; Leone F; Zini G; D'Onofrio G; Leone G; Piccirillo N
    Cytotherapy; 2003; 5(1):19-30. PubMed ID: 12745586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of G-CSF mobilized granulocyte transfusions in four neutropenic children with sepsis and invasive fungal infection.
    Grigull L; Schrauder A; Schmitt-Thomssen A; Sykora K; Welte K
    Infection; 2002 Oct; 30(5):267-71. PubMed ID: 12382084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic transfusions of granulocytes collected by simple bag method for children with cancer and neutropenic infections: results of a single-centre pilot study.
    Kikuta A; Ohto H; Nemoto K; Mochizuki K; Sano H; Ito M; Suzuki H
    Vox Sang; 2006 Jul; 91(1):70-6. PubMed ID: 16756604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment and prophylaxis of severe infections in neutropenic patients by granulocyte transfusions.
    Illerhaus G; Wirth K; Dwenger A; Waller CF; Garbe A; Brass V; Lang H; Lange W
    Ann Hematol; 2002 May; 81(5):273-81. PubMed ID: 12029537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
    Safdar A; Rodriguez GH; Lichtiger B; Dickey BF; Kontoyiannis DP; Freireich EJ; Shpall EJ; Raad II; Kantarjian HM; Champlin RE
    Cancer; 2006 Jun; 106(12):2664-71. PubMed ID: 16691620
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Collection of hematopoietic progenitor cells from healthy donors].
    Bojanić I; Cepulić BG; Mazić S
    Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value and practicality of granulocyte transfusion: a single oncology centre experience.
    Al-Tanbal H; Al Humaidan H; Al-Nounou R; Roberts G; Tesfamichael K; Owaidah T
    Transfus Med; 2010 Jun; 20(3):160-8. PubMed ID: 20070613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Granulocyte transfusions in the G-CSF era. Where do we stand?
    Robinson SP; Marks DI
    Bone Marrow Transplant; 2004 Nov; 34(10):839-46. PubMed ID: 15273712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and efficacy of therapeutic early onset granulocyte transfusions in pediatric patients with neutropenia and severe infections.
    Sachs UJ; Reiter A; Walter T; Bein G; Woessmann W
    Transfusion; 2006 Nov; 46(11):1909-14. PubMed ID: 17076845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect and safety of granulocyte transfusions in pediatric patients with febrile neutropenia or defective granulocyte functions.
    Atay D; Ozturk G; Akcay A; Yanasik M; Anak S; Devecioglu O
    J Pediatr Hematol Oncol; 2011 Aug; 33(6):e220-5. PubMed ID: 21792027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. G-CSF mobilised granulocyte transfusions in 32 paediatric patients with neutropenic sepsis.
    Grigull L; Pulver N; Goudeva L; Sykora KW; Linderkamp C; Beilken A; Seidemann K; Schmid H; Welte K; Heuft HG
    Support Care Cancer; 2006 Sep; 14(9):910-6. PubMed ID: 16622651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A dose-response analysis of lenograstim plus dexamethasone for neutrophil mobilization and collection.
    Heuft HG; Goudeva L; Pulver N; Grigull L; Schwella N; Blasczyk R
    Transfusion; 2005 Apr; 45(4):604-12. PubMed ID: 15819683
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective randomized trial to evaluate two delayed granulocyte colony stimulating factor administration schedules after high-dose cytarabine therapy in adult patients with acute lymphoblastic leukemia.
    Hofmann WK; Seipelt G; Langenhan S; Reutzel R; Schott D; Schoeffski O; Illiger HJ; Hartmann F; Balleisen L; Franke A; Fiedler F; Huber C; Rasche H; Bergmann L; Ganser A; Pott C; Pasold R; Rudolph C; Ottmann OG; Gökbuget N; Hoelzer D
    Ann Hematol; 2002 Oct; 81(10):570-4. PubMed ID: 12424538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor.
    Cavallaro AM; Lilleby K; Majolino I; Storb R; Appelbaum FR; Rowley SD; Bensinger WI
    Bone Marrow Transplant; 2000 Jan; 25(1):85-9. PubMed ID: 10654020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe chronic neutropenia: treatment and follow-up of patients in the Severe Chronic Neutropenia International Registry.
    Dale DC; Cottle TE; Fier CJ; Bolyard AA; Bonilla MA; Boxer LA; Cham B; Freedman MH; Kannourakis G; Kinsey SE; Davis R; Scarlata D; Schwinzer B; Zeidler C; Welte K
    Am J Hematol; 2003 Feb; 72(2):82-93. PubMed ID: 12555210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined treatment with amphotericin-B and granulocyte transfusion from G-CSF-stimulated donors in an aplastic patient with invasive aspergillosis undergoing bone marrow transplantation.
    Catalano L; Fontana R; Scarpato N; Picardi M; Rocco S; Rotoli B
    Haematologica; 1997; 82(1):71-2. PubMed ID: 9107088
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Granulocyte-colony-stimulating factor-mobilized prophylactic granulocyte transfusions given after allogeneic peripheral blood progenitor cell transplantation result in a modest reduction of febrile days and intravenous antibiotic usage.
    Oza A; Hallemeier C; Goodnough L; Khoury H; Shenoy S; Devine S; Augustin K; Vij R; Trinkaus K; Dipersio JF; Adkins D
    Transfusion; 2006 Jan; 46(1):14-23. PubMed ID: 16398726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized comparison of granulocyte colony-stimulating factor versus granulocyte-macrophage colony-stimulating factor plus intensive chemotherapy for peripheral blood stem cell mobilization and autologous transplantation in multiple myeloma.
    Arora M; Burns LJ; Barker JN; Miller JS; Defor TE; Olujohungbe AB; Weisdorf DJ
    Biol Blood Marrow Transplant; 2004 Jun; 10(6):395-404. PubMed ID: 15148493
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte transfusion therapy in pediatric patients after hematopoietic stem cell transplantation: a 5-year single tertiary care center experience.
    Pham HP; Rogoza K; Stotler B; Duffy D; Parker-Jones S; Ginzburg Y; Bhatia M; Cairo M; Schwartz J
    J Pediatr Hematol Oncol; 2012 Nov; 34(8):e332-6. PubMed ID: 22858567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.